10x Genomics' share price is down nearly 15% today and >70% year-to-date. The company offers innovative products for biological analysis but faces heavy losses and declining revenues of key products.

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company has ...

Buffeted for weeks by criticism from competitors and leading academic researchers in the spatial biology community, 10x Genomics is defending its strategy of aggressively litigating potential ...

10x Genomics is up 7.5% since the beginning of the year, and at $15.26 per share, it is trading close to its 52-week high of $16.47 from December 2024. Investors who bought $1,000 worth of 10x ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...

10x Banking unveils the world’s first ‘meta core’ platform for banks – a fast, straight-forward and derisked path to full transformation LONDON--(BUSINESS WIRE)--10x Banking, the cloud-native core ...

HUAWEI, then Samsung, debuted 10x cameras several years ago, offering a still-unprecedented level of reach for even the best modern camera phones. Unfortunately, the Galaxy S23 Ultra was the last of ...

Rand Fishkin coined the term “10x content” in a Whiteboard Friday video episode for Moz that was titled “Why Good Unique Content Needs to Die.” His definition of 10x content is “Content that is 10 ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.1% in the morning session after Piper Sandler initiated coverage on the stock with a Neutral rating and a $15.00 price target. While the ...